Tom Maniatis

Last updated
Tom Maniatis
Born (1943-05-08) May 8, 1943 (age 80)
Denver, Colorado
NationalityAmerican
Alma mater University of Colorado, Vanderbilt University
Known forThe development and application of gene cloning methods to the study of molecular biology.
AwardsThe Eli Lilly Research Award in Microbiology and Immunology, 1981
Richard Lounsbery Award, 1985
Member, National Academy of Sciences, 1985
Fellow, American Academy of Arts and Sciences, 1985
Pasarow Award in Cancer Research, 2001
Lasker-Koshland Special Achievement Award in Medical Science, 2012
Member, National Academy of Medicine, 2012
Scientific career
Fields Molecular Biology
Institutions Harvard University, Cold Spring Harbor Laboratory, California Institute of Technology, Columbia University
Doctoral advisor Leonard Lerman
Other academic advisors Mark Ptashne, Fred Sanger

Tom Maniatis (born May 8, 1943), is an American professor of molecular and cellular biology. He is a professor at Columbia University, and serves as the Scientific Director and CEO of the New York Genome Center. [1] [2]

Contents

Education

Maniatis received B.A. and M.S. degrees from the University of Colorado in Boulder, and a PhD in Molecular Biology from Vanderbilt University. [3] He carried out postdoctoral studies at Harvard University and at the Medical Research Council (MRC) Laboratory of Molecular Biology in Cambridge, England. [4]

Research and career

Maniatis developed and disseminated gene cloning technologies and their applications in the study of gene regulatory mechanisms. [5] [6]

cDNA Cloning

While an assistant professor of Biochemistry and Molecular Biology at Harvard, and a member of the Cold Spring Harbor Laboratory (CSHL) faculty, Maniatis collaborated with Drs. Fotis Kafatos and Argiris Efstratiadis to develop a method for synthesizing and cloning full length double stranded DNA copies of messenger RNA (termed “copy” or cDNA). [7] [8] [9] [10] This method provided a key step in the isolation of human genes, and in the production of “recombinant” proteins in mammalian cells in culture, a central process in the biotechnology industry. [11] [12]

Genomic DNA libraries

Maniatis joined the Department of Biology at the California Institute of Technology in Pasadena California, where his laboratory developed methods to isolate and study individual human genes. [13] This lab generated the first human genomic DNA library containing all of the genes in the human genome. [14]

Using genomic DNA library, the Maniatis lab isolated and characterized the entire “cluster” of human b-globin genes, which were the first human genes to be cloned and their DNA sequences determined. [15] His laboratory contributed fundamental insights into the mechanisms of RNA transcription, RNA splicing and the regulation of gene expression. [16] [17] [18]

Maniatis returned to Harvard in 1980 where he taught and continued his research. In 2010 he moved to Columbia University. [14] [19] While there he cofounded the New York Genome Center in 2010. He became the Scientific Director and CEO of the center in 2016. [1]

Molecular cloning manual

Maniatis was involved in the writing of the “Molecular Cloning Manual”. [20] In 1979, the Maniatis lab had developed and deployed gene cloning methods. Maniatis and Ed Fritsch taught a summer course in gene cloning at the Cold Spring Harbor Laboratory. [18] Based on the material presented in the course they collaborated with Joseph Sambrook, then the Scientific Director of the CSHL, to write the textbook.

Biotechnology companies

Maniatis and Mark Ptashne founded Genetics Institute, Inc. in 1980. [21] The company produced several FDA approved drugs “protein biologics” including blood clotting factors for the treatment of hemophilia, and erythropoietin for the treatment of anemia. [22] [23] [24] The company was acquired by Wyeth Pharmaceuticals.

In 1994, Maniatis, Fred Goldeberg, and others from the Harvard Medical School founded ProScript. [25] The company invented the proteasome inhibitor Velcade (Bortezomid) [26] approved by the FDA for the treatment of Multiple Myeloma. ProScript was acquired by Millennium/Takeda Pharma.

In 2004 Maniatis cofounded Acceleron Pharma, a TGF-b company that produced “ligand trap” drugs, including REBLOZYL ® for the treatment of Myodysplastic Syndrome (MDS) and b-thalassaemia. [27] [25]

Kallyope was founded by Maniatis, Charles Zuker, and Richard Axel in 2006. It focused on the development of drugs to treat metabolic and inflammatory disorders of the gut. [28]

Maniatis, David Goeddel, and William Rudder won the Brandeis University Jacob and Louise Gabbay Award in Biotechnology and Medicine in 1999. [29]

Service

Maniatis has served on the board of trustees of the Cold Spring Harbor Laboratory, the Jackson Laboratory, and the Rockefeller University. [30] [31] [13]

Maniatis led the ALS Association's initiative TREAT ALS (Translational Research Advancing Therapy for ALS) that combines drug discovery with priorities set for existing drug candidates, to accelerate clinical testing of compounds with promise for treating the disease. [32] [33] [34] He also served on the scientific advisory board of “Prize for Life” founded by Avichai Kremer. Maniatis’ won the Jacob F. Javits Lifetime Achievement Award in ALS research from the ALS Association. [13]

Maniatis was a cofounder of the New York Genome Center, headed its scientific steering committee, and has served as a member of its board of directors from its founding in 2011. [1]

Maniatis is founding director of the university-wide Columbia University Precision Medicine Initiative (CPMI), which is dedicated to the application of genomic technology to the advancement of basic and medical science, directed towards the practice of precision medicine (the use of genetic and genomic information to diagnose and treat human diseases). [21]

Awards

Maniatis has received Honorary PhD degrees from the University of Athens, the Cold Spring Harbor Graduate School of Biological Sciences, and the Rockefeller University. [38] [1]

Maniatis was elected to the U.S. National Academy of Sciences, and the American Academy of Arts and Sciences in 1985, and the U.S. National Academy of Medicine in 2012. [17] [2] [39]

Related Research Articles

Molecular biology is a branch of biology that seeks to understand the molecular basis of biological activity in and between cells, including biomolecular synthesis, modification, mechanisms, and interactions.

A restriction enzyme, restriction endonuclease, REase, ENase orrestrictase is an enzyme that cleaves DNA into fragments at or near specific recognition sites within molecules known as restriction sites. Restriction enzymes are one class of the broader endonuclease group of enzymes. Restriction enzymes are commonly classified into five types, which differ in their structure and whether they cut their DNA substrate at their recognition site, or if the recognition and cleavage sites are separate from one another. To cut DNA, all restriction enzymes make two incisions, once through each sugar-phosphate backbone of the DNA double helix.

In genetics, an expressed sequence tag (EST) is a short sub-sequence of a cDNA sequence. ESTs may be used to identify gene transcripts, and were instrumental in gene discovery and in gene-sequence determination. The identification of ESTs has proceeded rapidly, with approximately 74.2 million ESTs now available in public databases. EST approaches have largely been superseded by whole genome and transcriptome sequencing and metagenome sequencing.

<span class="mw-page-title-main">Recombinant DNA</span> DNA molecules formed by human agency at a molecular level generating novel DNA sequences

Recombinant DNA (rDNA) molecules are DNA molecules formed by laboratory methods of genetic recombination that bring together genetic material from multiple sources, creating sequences that would not otherwise be found in the genome.

<span class="mw-page-title-main">Robert G. Roeder</span> American biochemist

Robert G. Roeder is an American biochemist. He is known as a pioneer scientist in eukaryotic transcription. He discovered three distinct nuclear RNA polymerases in 1969 and characterized many proteins involved in the regulation of transcription, including basic transcription factors and the first mammalian gene-specific activator over five decades of research. He is the recipient of the Gairdner Foundation International Award in 2000, the Albert Lasker Award for Basic Medical Research in 2003, and the Kyoto Prize in 2021. He currently serves as Arnold and Mabel Beckman Professor and Head of the Laboratory of Biochemical and Molecular Biology at The Rockefeller University.

Patrick Cramer is a German chemist, structural biologist, and molecular systems biologist. In 2020, he was honoured to be an international member of the National Academy of Sciences. He became president of the Max Planck Society in June 2023.

<span class="mw-page-title-main">Roger D. Kornberg</span> American biochemist and professor of structural biology

Roger David Kornberg is an American biochemist and professor of structural biology at Stanford University School of Medicine. Kornberg was awarded the Nobel Prize in Chemistry in 2006 for his studies of the process by which genetic information from DNA is copied to RNA, "the molecular basis of eukaryotic transcription."

<span class="mw-page-title-main">Carol W. Greider</span> American molecular biologist and Nobel laureate

Carolyn Widney Greider is an American molecular biologist and Nobel laureate. She joined the University of California, Santa Cruz as a Distinguished Professor in the department of molecular, cell, and developmental biology in October 2020.

<span class="mw-page-title-main">Vincent Racaniello</span> American biologist

Vincent R. Racaniello is a Higgins Professor in the Department of Microbiology and Immunology at Columbia University's College of Physicians and Surgeons. He is a co-author of a textbook on virology, Principles of Virology.

<span class="mw-page-title-main">PBX1</span> Protein found in humans

Pre-B-cell leukemia transcription factor 1 is a protein that in humans is encoded by the PBX1 gene. The homologous protein in Drosophila is known as extradenticle, and causes changes in embryonic development.

<span class="mw-page-title-main">Helen Blau</span> American biochemist

Helen Margaret Blau is an American biologist and the Donald E. and Delia B. Baxter Foundation Professor and Director of the Baxter Laboratory for Stem Cell Biology at Stanford University School of Medicine. She is known for establishing the reversibility of the mammalian differentiated state. Her landmark papers showed that nuclear reprogramming and the activation of novel programs of gene expression were possible, overturning the prevailing view that the differentiated state was fixed and irreversible. Her discoveries opened the door for cellular reprogramming and its application to stem cell biology.

<span class="mw-page-title-main">Lydia Villa-Komaroff</span> Mexican American cellular biologist

Lydia Villa-Komaroff is a molecular and cellular biologist who has been an academic laboratory scientist, a university administrator, and a business woman. She was the third Mexican-American woman in the United States to receive a doctorate degree in the sciences (1975) and is a co-founding member of The Society for the Advancement of Chicanos/Hispanics and Native Americans in Science (SACNAS). Her most notable discovery was in 1978 during her post-doctoral research, when she was part of a team that discovered how bacterial cells could be used to generate insulin.

<span class="mw-page-title-main">Don W. Cleveland</span> American cancer biologist and neurobiologist

Don W. Cleveland is an American cancer biologist and neurobiologist.

Ruth Lehmann is a developmental and cell biologist. She is the Director of the Whitehead Institute for Biomedical Research. She previously was affiliated with the New York University School of Medicine, where she was the Director of the Skirball Institute of Biomolecular Medicine, the Laura and Isaac Perlmutter Professor of Cell Biology, and the Chair of the Department of Cell Biology. Her research focuses on germ cells and embryogenesis.

Ross C. Hardison is an American biochemist and molecular biologist, currently the T. Ming Chu Professor of Biochemistry and Molecular Biology at the Eberly College of Science, of the Pennsylvania State University.

<span class="mw-page-title-main">Richard Treisman</span> British scientist

Sir Richard Henry Treisman is a British scientist specialising in the molecular biology of cancer. Treisman is a director of research at the Francis Crick Institute in London.

Anindya Dutta is an Indian-born American biochemist and cancer researcher, a Chair of the Department of Genetics at the University of Alabama at Birmingham School of Medicine since 2021, who has served as Chair of the Department of Biochemistry and Molecular Genetics at the University of Virginia School of Medicine in 2011–2021. Dutta's research has focused on the mammalian cell cycle with an emphasis on DNA replication and repair and on noncoding RNAs. He is particularly interested in how de-regulation of these processes promote cancer progression. For his accomplishments he has been elected a Fellow of the American Association for the Advancement of Science, received the Ranbaxy Award in Biomedical Sciences, the Outstanding Investigator Award from the American Society for Investigative Pathology, the Distinguished Scientist Award from the University of Virginia and the Mark Brothers Award from the Indiana University School of Medicine.

Edward Francis Fritsch is a scientist in the field of molecular biology and cancer immunology.

<span class="mw-page-title-main">Francisco Ernesto Baralle</span> Argentinian geneticist

Francisco Ernesto (Tito) Baralle is an Argentinian geneticist best known for his innovations in molecular biology and in particular the discovery of how genes are processed and mechanisms in mRNA splicing.

Robin Elizabeth Reed was an American professor of cell biology at the Harvard Medical School. Her research considered the molecular mechanisms that underpin neurodegenerative disease.

References

  1. 1 2 3 4 "Tom Maniatis, PhD". New York Genome Center. 4 December 2019. Retrieved 2021-06-21.
  2. 1 2 "Tom Maniatis". zuckermaninstitute.columbia.edu. 2017-03-06. Retrieved 2021-06-21.
  3. ↑ "Tom Maniatis | Icahn School of Medicine". Icahn School of Medicine at Mount Sinai. Retrieved 2021-06-21.
  4. 1 2 "Physio - Tom Maniatis Profile". www.physiology.columbia.edu. Retrieved 2021-06-21.
  5. ↑ Manoli, Devanand S.; Tollkuhn, Jessica (2018). "Gene regulatory mechanisms underlying sex differences in brain development and psychiatric disease". Annals of the New York Academy of Sciences. 1420 (1): 26–45. Bibcode:2018NYASA1420...26M. doi:10.1111/nyas.13564. ISSN   0077-8923. PMC   5991992 . PMID   29363776.
  6. ↑ Qiu, Zilong; Ghosh, Anirvan (2008-11-06). "A Brief History of Neuronal Gene Expression: Regulatory Mechanisms and Cellular Consequences". Neuron. 60 (3): 449–455. doi: 10.1016/j.neuron.2008.10.039 . ISSN   0896-6273. PMID   18995819.
  7. ↑ Sim, G. K.; Kafatos, F. C.; Jones, C. W.; Koehler, M. D.; Efstratiadis, A.; Maniatis, T. (1979). "Use of a cDNA library for studies on evolution and developmental expression of the chorion multigene families". Cell. 18 (4): 1303–1316. doi: 10.1016/0092-8674(79)90241-1 . ISSN   0092-8674. PMID   519770.
  8. ↑ Gao, Xinghong; Jia, Renyong; Wang, Mingshu; Zhu, Dekang; Chen, Shun; Lin, Meng; Yin, Zhongqiong; Wang, Yin; Chen, Xiaoyue; Cheng, Anchun (2014-01-01). "Construction and identification of a cDNA library for use in the yeast two-hybrid system from duck embryonic fibroblast cells post-infected with duck enteritis virus". Molecular Biology Reports. 41 (1): 467–475. doi:10.1007/s11033-013-2881-z. ISSN   1573-4978. PMID   24293127. S2CID   10291314.
  9. ↑ Forde, Brian G. (1983), Walker, John M.; Gaastra, Wim (eds.), "Synthesis of cDNA for Molecular Cloning", Techniques in Molecular Biology, Dordrecht: Springer Netherlands, pp. 167–183, doi:10.1007/978-94-011-6563-1_9, ISBN   978-94-011-6563-1 , retrieved 2021-06-21
  10. ↑ Efstratiadis, A.; Kafatos, F. C.; Maxam, A. M.; Maniatis, T. (1976). "Enzymatic in vitro synthesis of globin genes". Cell. 7 (2): 279–288. doi:10.1016/0092-8674(76)90027-1. ISSN   0092-8674. PMID   60178. S2CID   41899832.
  11. ↑ Mattaliano, R. J.; Rosa, J. J.; Foeller, C.; Woodard, J. P.; Bertolini, M. J. (1987), Walsh, Kenneth A. (ed.), "Analysis of Recombinant Proteins — Current Trends and Practical Limits in Analytical Stringency", Methods in Protein Sequence Analysis · 1986, Experimental Biology and Medicine, Totowa, NJ: Humana Press, pp. 79–95, doi:10.1007/978-1-59259-480-1_6, ISBN   978-1-59259-480-1 , retrieved 2021-06-21
  12. ↑ Horvath, Henriette; Huang, Jintai; Wong, Oi; Kohl, Elizabeth; Okita, Thomas; Kannangara, C. Gamini; von Wettstein, Diter (2000-02-15). "The production of recombinant proteins in transgenic barley grains". Proceedings of the National Academy of Sciences of the United States of America. 97 (4): 1914–1919. Bibcode:2000PNAS...97.1914H. doi: 10.1073/pnas.030527497 . ISSN   0027-8424. PMC   26536 . PMID   10677555.
  13. 1 2 3 "Thomas Maniatis, Ph.D." Events & Lectures. Retrieved 2021-06-21.
  14. 1 2 "TOM MANIATIS: GENE EXPRESSION, CLONING AND BEYOND". Harvard University - Department of Molecular & Cellular Biology. 2004-11-16. Retrieved 2021-06-21.
  15. 1 2 "Tom Maniatis: Mastering Methods and Exploring Molecular Mechanisms". Rita Allen Foundation. August 9, 2016. Retrieved 2021-06-21.
  16. ↑ "mRNA Splicing: Forty years from Discovery to Therapeutics - Tom Maniatis - RNA transcription, splicing and stochastic promoter choice in the Protocadherin α gene cluster". library.cshl.edu. Retrieved 2021-06-21.
  17. 1 2 "Thomas Maniatis". www.nasonline.org. Retrieved 2021-06-21.
  18. 1 2 3 4 "Tom Maniatis: A Deep Sense that Science Must Be Shared". Columbia University Irving Medical Center. 2012-09-10. Retrieved 2021-06-21.
  19. ↑ "A LASKER GOES TO . . . TOM MANIATIS, FORMER MCB PROFESSOR". Harvard University - Department of Molecular & Cellular Biology. 2012-10-24. Retrieved 2021-06-21.
  20. ↑ Creager, Angela N. H. (2020). "Recipes for recombining DNA: A history of Molecular Cloning: A Laboratory Manual". BJHS Themes. 5: 225–243. doi: 10.1017/bjt.2020.5 . ISSN   2058-850X.
  21. 1 2 "Tom Maniatis | Precision Medicine". precisionmedicine.columbia.edu. Retrieved 2021-06-21.
  22. ↑ "Wyeth Biopharma - 183 Employees - US Staff". bearsofficialsstore.com. Retrieved 2021-06-21.
  23. ↑ Georgopoulos, Dimitris; Matamis, Dimitris; Routsi, Christina; Michalopoulos, Argiris; Maggina, Nina; Dimopoulos, George; Zakynthinos, Epaminondas; Nakos, George; Thomopoulos, George; Mandragos, Kostas; Maniatis, Alice (2005-10-05). "Recombinant human erythropoietin therapy in critically ill patients: a dose-response study [ISRCTN48523317]". Critical Care. 9 (5): R508–515. doi: 10.1186/cc3786 . ISSN   1466-609X. PMC   1297615 . PMID   16277712.
  24. ↑ Maniatis, G. M.; Rifkind, R. A.; Bank, A.; Marks, P. A. (1973). "Early stimulation of RNA synthesis by erythropoietin in cultures of erythroid precursor cells". Proceedings of the National Academy of Sciences of the United States of America. 70 (11): 3189–3194. Bibcode:1973PNAS...70.3189M. doi: 10.1073/pnas.70.11.3189 . ISSN   0027-8424. PMC   427198 . PMID   4522297.
  25. 1 2 "Tom Maniatis, Ph.D." Acceleron Pharma Inc. Retrieved 2021-06-21.
  26. ↑ Rossi, M.; Oberst, A.; Sayan, A. Emre; Salomoni, P. (2005). "Proteasome inhibitors in cancer therapy: death by indigestion". Cell Death & Differentiation. 12 (9): 1255–1257. doi: 10.1038/sj.cdd.4401701 . ISSN   1476-5403.
  27. ↑ "Acceleron Announces Retirement of Director and Co-Founder Tom Maniatis". Bloomberg. 10 June 2019. Retrieved 2021-06-21.
  28. ↑ "Kallyope". Kallyope. Retrieved 2021-06-21.
  29. ↑ "Past Winners". www.brandeis.edu. Retrieved 2021-06-21.
  30. ↑ "Tom Maniatis". Cold Spring Harbor Laboratory. Retrieved 2021-06-21.
  31. ↑ "006908 - B6.Cg-Ikbke/J". www.jax.org. Retrieved 2021-06-21.
  32. ↑ "TREAT ALS - The ALS Association". web.alsa.org. Retrieved 2021-06-21.
  33. ↑ Poppe, Lindsay; Rué, Laura; Robberecht, Wim; Van Den Bosch, Ludo (2014-12-01). "Translating biological findings into new treatment strategies for amyotrophic lateral sclerosis (ALS)". Experimental Neurology. 262: 138–151. doi: 10.1016/j.expneurol.2014.07.001 . ISSN   0014-4886. PMID   25017368.
  34. ↑ Mao, Zhijuan; Zhang, Suming; Chen, Hong (2015-11-19). "Stem cell therapy for amyotrophic lateral sclerosis". Cell Regeneration. 4: 4:11. doi: 10.1186/s13619-015-0026-7 . ISSN   2045-9769. PMC   4653876 . PMID   26594318.
  35. ↑ "Richard Lounsbery Award". www.nasonline.org. Retrieved 2021-06-21.
  36. ↑ "Thomas Maniatis, Ph.D." The Milstein Awards. 2003-06-21. Retrieved 2021-06-21.
  37. ↑ "Tom Maniatis Honored with 2012 Lasker-Koshland Award". Columbia University Irving Medical Center. 2012-09-10. Retrieved 2021-06-21.
  38. ↑ "Tom Maniatis - Greek blood runs through my veins". www.ellines.com. Retrieved 2021-06-21.
  39. ↑ "Tom Maniatis". BioFrontiers Institute. 2017-05-02. Retrieved 2021-06-21.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.